Rachel McMinn, Chief Strategy Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 130 shares at $123.12 ($16K) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Open-market sale of $16k ICPT by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2017-10-04 | $17K | — | Filing → |
| ICPT | SELL | 2017-07-05 | $31K | — | Filing → |
| ICPT | SELL | 2017-05-03 | $13K | — | Filing → |